Torii Pharmaceutical Co., Ltd. (4551) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Torii Pharmaceutical Co., Ltd. (4551) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Torii Pharmaceutical Co., Ltd. (4551) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Torii Pharmaceutical Co., Ltd. (4551) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
24 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Torii Pharmaceutical Co., Ltd. (Torii) a subsidiary of Japan Tobacco Inc. is a pharmaceutical company that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment of renal diseases, acute diseases, hemodialysis, HIV infection, skin diseases and lifestyle-related diseases. Its antebate agent is used for the treatment of the inflammatory manifestations of dermatosis. Torii markets its products through its network of distributors.

Torii Pharmaceutical Co., Ltd. (4551) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal

  
Source:
Document ID
GDPH81862D
Country
Industry
Ticker
4551=JP
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Torii Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Torii Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Torii Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Torii Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Torii Pharmaceutical Co., Ltd., Medical Devices Deals, 2010 to YTD 201691
Torii Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Torii Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deal Details1110
  Partnerships111
    Japan Tobacco, Torii Pharmac and Sumitomo Dainippon Pharma Enter into Partnership111
    Japan Tobacco Enters into Agreement with Torii Pharma121
    Japan Tobacco Enters Into Co-Marketing Agreement With Torii Pharma For JTK-303131
    Toray, Japan Tobacco And Torii Terminate Joint Development Agreement For TRK-820142
    Riken Enters Into Co-Development Agreement With Torii Pharma161
  Licensing Agreements171
    Japan Tobacco, Torii Pharmaceutical Enter into Licensing Agreement with Menlo Therapeutics171
    Japan Tobacco, Torii Pharmac Enter into Licensing Agreement with ALK-Abello181
    ALK-Abello Enters Into Licensing Agreement With Torii Pharma For Alutard And MITIZAX192
Torii Pharmaceutical Co., Ltd. - Key Competitors211
Key Employees221
Locations And Subsidiaries231
  Head Office231
Appendix241
  Methodology241
  About GlobalData241
  Contact Us241
  Disclaimer241

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Torii Pharmaceutical Co., Ltd. (4551) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Torii-Pharmaceutical-Co-Ltd-4551-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7707>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Torii Pharmaceutical Co., Ltd. (4551) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Torii-Pharmaceutical-Co-Ltd-4551-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7707>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research